EDGAR Filing Documents for 0001387131-20-003918

Form 8-K - Current report:

SEC Accession No. 0001387131-20-003918

Filing Date

2020-04-15

Accepted

2020-04-15 17:16:40

Documents

Period of Report

2020-04-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	admp-8k_041320.htm	8-K	38992
2	EXHIBIT 10.1	ex10-1.htm	EX-10.1	57329
3	PRESS RELEASE DATED APRIL 15, 2020	ex99-1.htm	EX-99.1	9847
4	GRAPHIC	ex1001.jpg	GRAPHIC	5761
5	GRAPHIC	ex991-001.jpg	GRAPHIC	2815
	Complete submission text file	0001387131-20-003918.txt		119753

Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130

Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)